Khadeeja Mohamed

1.1k total citations
13 papers, 436 citations indexed

About

Khadeeja Mohamed is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Surgery. According to data from OpenAlex, Khadeeja Mohamed has authored 13 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Pharmacology and 3 papers in Surgery. Recurrent topics in Khadeeja Mohamed's work include Malaria Research and Control (4 papers), Pregnancy and preeclampsia studies (2 papers) and Neonatal Health and Biochemistry (2 papers). Khadeeja Mohamed is often cited by papers focused on Malaria Research and Control (4 papers), Pregnancy and preeclampsia studies (2 papers) and Neonatal Health and Biochemistry (2 papers). Khadeeja Mohamed collaborates with scholars based in United Kingdom, United States and Switzerland. Khadeeja Mohamed's co-authors include Janet Rowan, Ruth Hughes, M. Peter Moore, Joanna Gullam, Justin A. Green, Stephan Duparc, Ann K. Miller, Ashwin Ravichandran, Richard L. Tweedie and David A. Heck and has published in prestigious journals such as PLoS ONE, Diabetes Care and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Khadeeja Mohamed

12 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khadeeja Mohamed United Kingdom 8 171 144 137 135 36 13 436
P Raynauld Canada 5 178 1.0× 125 0.9× 47 0.3× 44 0.3× 7 0.2× 5 370
Emad M. Ibrahim Egypt 10 132 0.8× 139 1.0× 24 0.2× 107 0.8× 5 0.1× 13 341
Santanu Acharya United Kingdom 9 115 0.7× 67 0.5× 15 0.1× 87 0.6× 36 1.0× 28 264
Suyog M. Joshi India 8 59 0.3× 91 0.6× 23 0.2× 49 0.4× 3 0.1× 10 364
Renu Misra India 12 114 0.7× 60 0.4× 125 0.9× 74 0.5× 3 0.1× 19 341
Hyun-Kyong Ahn South Korea 14 239 1.4× 194 1.3× 30 0.2× 107 0.8× 10 0.3× 20 424
Ali Taner Anuk Türkiye 12 324 1.9× 125 0.9× 21 0.2× 156 1.2× 4 0.1× 20 464
Kevin R. Dufendach United States 8 56 0.3× 75 0.5× 38 0.3× 37 0.3× 6 0.2× 24 253
Tahereh Poordast Iran 10 187 1.1× 36 0.3× 17 0.1× 70 0.5× 6 0.2× 21 310

Countries citing papers authored by Khadeeja Mohamed

Since Specialization
Citations

This map shows the geographic impact of Khadeeja Mohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khadeeja Mohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khadeeja Mohamed more than expected).

Fields of papers citing papers by Khadeeja Mohamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khadeeja Mohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khadeeja Mohamed. The network helps show where Khadeeja Mohamed may publish in the future.

Co-authorship network of co-authors of Khadeeja Mohamed

This figure shows the co-authorship network connecting the top 25 collaborators of Khadeeja Mohamed. A scholar is included among the top collaborators of Khadeeja Mohamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khadeeja Mohamed. Khadeeja Mohamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gravas, Stavros, Claus G. Roehrborn, Matthias Oelke, et al.. (2023). Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression. Prostate Cancer and Prostatic Diseases. 27(3). 469–477.
2.
Vélez, Iván Darío, Tran Tinh Hien, Justin A. Green, et al.. (2021). Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial. The Lancet Child & Adolescent Health. 6(2). 86–95. 7 indexed citations
4.
Rueangweerayut, Ronnatrai, Germana Bancone, Andrew P. Beelen, et al.. (2017). Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers. American Journal of Tropical Medicine and Hygiene. 97(3). 702–711. 72 indexed citations
5.
Fukuda, Mark M., Srivicha Krudsood, Khadeeja Mohamed, et al.. (2017). A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria. PLoS ONE. 12(11). e0187376–e0187376. 26 indexed citations
6.
Green, Justin A., Khadeeja Mohamed, Navin Goyal, et al.. (2016). Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. 60(12). 7321–7332. 23 indexed citations
7.
Hughes, Ruth, M. Peter Moore, Joanna Gullam, Khadeeja Mohamed, & Janet Rowan. (2015). An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes. Obstetrical & Gynecological Survey. 70(3). 151–153. 3 indexed citations
8.
Green, Justin A., Bela Patel, Azra Hussaini, et al.. (2014). Tafenoquine at therapeutic concentrations does not prolong fridericia‐corrected QT interval in healthy subjects. The Journal of Clinical Pharmacology. 54(9). 995–1005. 29 indexed citations
9.
Hughes, Ruth, M. Peter Moore, Joanna Gullam, Khadeeja Mohamed, & Janet Rowan. (2014). An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes. Diabetes Care. 37(11). 2953–2959. 178 indexed citations
10.
Sundar, Shyam, et al.. (2011). Pharmacokinetics of Oral Sitamaquine Taken with or without Food and Safety and Efficacy for Treatment of Visceral Leishmaniais: A Randomized Study in Bihar, India. American Journal of Tropical Medicine and Hygiene. 84(6). 892–900. 20 indexed citations
11.
Mohamed, Khadeeja, Andrew Embleton-Thirsk, & Robert L. Cuffe. (2011). Adjusting for covariates in non‐inferiority studies with margins defined as risk differences. Pharmaceutical Statistics. 10(5). 461–466. 3 indexed citations
12.
Saleh, Khaled J., Daryll C. Dykes, Richard L. Tweedie, et al.. (2002). Functional outcome after total knee arthroplasty revision. The Journal of Arthroplasty. 17(8). 967–977. 61 indexed citations
13.
Mohamed, Khadeeja, et al.. (2000). Understanding of functions among Maldivian teacher education students. 291–298. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026